Shouyao Holdings (Beijing) Co. Ltd. A (688197) - Total Assets
Based on the latest financial reports, Shouyao Holdings (Beijing) Co. Ltd. A (688197) holds total assets worth CN¥725.73 Million CNY (≈ $106.20 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Shouyao Holdings (Beijing) Co. Ltd. A - Total Assets Trend (2019–2025)
This chart illustrates how Shouyao Holdings (Beijing) Co. Ltd. A's total assets have evolved over time, based on quarterly financial data. Also see 688197 company net worth for the company's overall valuation and market capitalisation.
Shouyao Holdings (Beijing) Co. Ltd. A - Asset Composition Analysis
Current Asset Composition (December 2025)
Shouyao Holdings (Beijing) Co. Ltd. A's total assets of CN¥725.73 Million consist of 89.1% current assets and 10.9% non-current assets. Review 688197 current and long-term liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 2.2% |
| Accounts Receivable | CN¥331.67K | 0.0% |
| Inventory | CN¥3.08 Million | 0.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥491.94K | 0.1% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2019–2025)
This chart illustrates how Shouyao Holdings (Beijing) Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Shouyao Holdings (Beijing) Co. Ltd. A share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shouyao Holdings (Beijing) Co. Ltd. A's current assets represent 89.1% of total assets in 2025, a decrease from 94.8% in 2019.
- Cash Position: Cash and equivalents constituted 2.2% of total assets in 2025, down from 64.9% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 0.4% of total assets.
Shouyao Holdings (Beijing) Co. Ltd. A Competitors by Total Assets
Key competitors of Shouyao Holdings (Beijing) Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Abivax SA
PA:ABVX
|
France | €547.14 Million |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
|
China | CN¥37.46 Billion |
|
Braveheart Bio, Inc. Common Stock
NASDAQ:BRVE
|
USA | $126.96 Million |
|
Neuren Pharmaceuticals Ltd
AU:NEU
|
Australia | AU$331.25 Million |
|
Lifecome Biochemistry Co Ltd
SHE:002868
|
China | CN¥729.16 Million |
|
Pulike Biological Engineering
SHG:603566
|
China | CN¥3.09 Billion |
|
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
|
USA | $423.10 Million |
|
NEWRON PHARMACEUT. EO-20
XETRA:NP5
|
Germany | €40.03 Million |
Shouyao Holdings (Beijing) Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.51 | 6.16 | 14.78 |
| Quick Ratio | 6.46 | 6.13 | 14.74 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥561.44 Million | CN¥589.30 Million | CN¥1.32 Billion |
Shouyao Holdings (Beijing) Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between Shouyao Holdings (Beijing) Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.47 |
| Latest Market Cap to Assets Ratio | 1.07 |
| Asset Growth Rate (YoY) | -14.2% |
| Total Assets | CN¥791.23 Million |
| Market Capitalization | $850.47 Million USD |
Valuation Analysis
Above Book Valuation: The market values Shouyao Holdings (Beijing) Co. Ltd. A's assets above their book value (1.07x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Shouyao Holdings (Beijing) Co. Ltd. A's assets decreased by 14.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Shouyao Holdings (Beijing) Co. Ltd. A (2019–2025)
The table below shows the annual total assets of Shouyao Holdings (Beijing) Co. Ltd. A from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥791.23 Million ≈ $115.78 Million |
-14.20% |
| 2024-12-31 | CN¥922.23 Million ≈ $134.95 Million |
-17.07% |
| 2023-12-31 | CN¥1.11 Billion ≈ $162.74 Million |
-14.40% |
| 2022-12-31 | CN¥1.30 Billion ≈ $190.12 Million |
+2133.32% |
| 2021-12-31 | CN¥58.18 Million ≈ $8.51 Million |
-68.06% |
| 2020-12-31 | CN¥182.13 Million ≈ $26.65 Million |
-16.79% |
| 2019-12-31 | CN¥218.89 Million ≈ $32.03 Million |
-- |
About Shouyao Holdings (Beijing) Co. Ltd. A
Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of drugs in China. The company offers drugs for oncology indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, China.